• Pluto Biosciences Launches Cloud-based Collaborative Life Sciences Platform for Academia, Biotech and Pharma Organizations

    Aug 20, 2021, 11:40 AM by
    Pluto, a Denver-based biotech software startup, launched it's secure, collaborative life sciences platform to be the digital lab space for life sciences teams of all sizes, anywhere in the world. The Pluto platform leverages technology developed at Harvard's Wyss Institute and simplifies secure, collaborative data sharing and bioinformatics analysis for academic, biotech, and pharmaceutical organizations, enabling them to make discoveries faster and more efficiently.
    Full story
  • Sensyne Health and Sentara Healthcare Form New Partnership for Ethical Data Sharing and Design of New Clinical Algorithms

    Aug 20, 2021, 11:40 AM by
    Full story
  • Three Reasons Biopharma Companies Can’t Afford To Miss The Digital Revolution

    Aug 20, 2021, 01:00 AM by User Not Found
    Bio-IT World | In the biopharmaceutical industry, there’s no shortage of data—the issue organizations more often face is how to capture data in ways that derive insight from it. Rather than stitching together a patchwork of data from disparate systems after the fact, more emphasis should be placed on capturing data in context, right at the point of execution.
    Full story
  • Ovarian Cancer Chip Model Reveals Drug Repurposing Opportunities

    Aug 17, 2021, 01:00 AM by User Not Found
    Bio-IT World | A novel organ-on-a-chip model of ovarian cancer has been used to showcase the sinister activities of tumors, including use of circulating platelets to fuel their growth and undermine treatment with chemotherapeutic drugs. The model also demonstrated the potential of an anti-platelet drug, currently in clinical trials for a different condition: to fight back.
    Full story
  • Unchanging Rules Of Gene Expression Could Improve Drug Approval Odds

    Aug 13, 2021, 01:00 AM by User Not Found
    Bio-IT World | Network theory holds that everything is connected—including if the “nodes” are human cells, genomes, proteomes, or transcriptomes. It is “pure, algorithm-run precision math,” and it could be an entirely new approach to big data science that could erase the declining odds that a drug entering clinical studies will exit a winner.
    Full story
  • Spanish Team Builds Neural Network to Predict Small Molecule Characteristics

    Aug 11, 2021, 05:24 AM by User Not Found
    Bio-IT World | A team of researchers in Barcelona have gathered bioactivity information for a million molecules using deep machine-learning computational models and a database of experimental results. Both the experimental results and the machine learning tool are available to the community at bioactivitysignatures.org.
    Full story
  • AI in Healthcare: Lessons Learned From Moffitt Cancer Center, Mayo Clinic

    Aug 10, 2021, 01:00 AM by User Not Found
    Bio-IT World | Until recently, Ross Mitchell served as the inaugural AI Officer at the Moffitt Cancer Center in Tampa, Florida. Now he’s offering consulting expertise borne of a long career applying AI to healthcare and health systems.
    Full story
  • Follow the Money: RNA Therapeutics, AI-Driven Therapy Design

    Aug 5, 2021, 05:26 AM by User Not Found
    Bio-IT World | Deep Genomics nets cash for AI-designed RNA therapeutics, Strata advances personalized minimal residual disease (MRD) assays, Frontier Medicines goes after the proteome, and more.
    Full story
  • #BioIT21: Insider’s Guide to Making the Most of the Hybrid Program

    Aug 4, 2021, 01:00 AM by User Not Found
    Bio-IT World | The Bio-IT World Conference and Expo will be happening both in-person and online this year—giving our community even more options for learning and connection. We’ve been busy marking our schedules and making our plans. Here are our best tips for making the most both the in person and online options.
    Full story
  • NVIDIA’s Synthetic Brain Images, Genomic Research Diversity, New Products

    Aug 3, 2021, 01:00 AM by User Not Found
    Bio-IT World | Kings College London uses NVIDIA’s Cambridge-1 supercomputer to build synthetic brain images, Singapore researcher detect SARS-CoV-2 in wastewater, American Heart Association Issues statement on genomic research diversity, and biobank acquisitions. Plus new products from 10x Genomics, Paradigm4, Thermo Fisher, Cresset.
    Full story
  • Russia Will Introduce Special Digital Genetic Passports

    Jul 29, 2021, 01:00 AM by User Not Found
    Bio-IT World | Russia plans to introduce special digital genetic passports that will contain genome sequencing of each citizen of the country—the data could be further used for the formation of genetic profiles and identification of susceptibility to diseases, according to recent statements made by some senior officials of the Russian federal government and analysts.
    Full story
  • Duke, Regeneron, Micronoma Named 2021 Bio-IT World Innovative Practices Winners

    Jul 28, 2021, 01:00 AM by User Not Found
    Bio-IT World | Bio-IT World has announced the 2021 Innovative Practices Awards winners. Grand prize awards were granted to Duke Cancer Institute with University of California, San Francisco, Micronoma, and Regeneron Pharmaceuticals. Pure Storage and the Folding@home project received honorable mention recognition. All four groups will be presenting their projects at the 2021 Bio-IT World Conference & Expo in Boston in September.
    Full story
  • NHGRI Takes New, WGS Look at Mendelian Diseases

    Jul 27, 2021, 01:00 AM by User Not Found
    Bio-IT World | The National Institutes of Health has made a five-year, nearly $80 million commitment to the establishment of a Mendelian Genomics Research Consortium of five clinical laboratories and one data coordinating center. The Consortium will build on previous National Human Genome Research Institute (NHGRI) work to develop new methods for identifying the genetic causes of single-gene diseases.
    Full story
  • Sema4 Begins Trading, Eyes Healthcare Partnerships, Liquid Biopsy

    Jul 23, 2021, 01:00 AM by User Not Found
    Bio-IT World | The board members of both Sema4 and CM Life Sciences voted this week to approve the special purpose acquisition company. The resulting combined company, Sema4 Holdings Corp, will commence trading of its shares of common stock and warrants on the Nasdaq Global Select Market under the ticker symbols "SMFR" and “SMFRW” today or Monday.
    Full story
  • DeepMind Releases Open Protein Structure Database Including Complete Human Proteome

    Jul 22, 2021, 11:11 AM by User Not Found
    Bio-IT World | DeepMind and the European Molecular Biology Laboratory (EMBL) today unveiled the most complete and accurate database of predicted protein structure models for the human proteome. The database includes about 350,000 protein structures and will be freely and openly available to the scientific community.
    Full story
  • PacBio Acquires Short-Read Sequencer Omniome for $800M

    Jul 20, 2021, 12:34 PM by User Not Found
    Bio-IT World | Pacific Biosciences announced this morning that it has signed a definitive merger agreement under which it will acquire Omniome, a San Diego-based company developing a highly differentiated, proprietary short-read sequencing platform capable of delivering high accuracy.
    Full story
  • Pfizer’s Digital Strategy and Transformation

    Jul 20, 2021, 12:24 PM by User Not Found
    Bio-IT World | Bill Leister, Pfizer’s Senior Vice President of Advanced Analytics and Data Platforms & Learning and Development, discusses the pandemic, platforms, and Pfizer’s digital vision.
    Full story
  • Why NLP Is the Key to Interpreting Unstructured Data in Pharma Drug Discovery

    Jul 19, 2021, 01:00 AM by User Not Found
    Bio-IT World | Natural language processing can help the pharma industry assess the market potential of a new drug, as well as target patient populations more accurately for existing drugs. NLP is much faster than human processing and can standardize mass amounts of both qualitative and quantitative unstructured data quickly into usable information with actionable insights.
    Full story
  • Inflammatory Clock Measures ‘Universal’ Hallmark Of Aging

    Jul 15, 2021, 09:19 AM by User Not Found
    Bio-IT World | Systemic chronic inflammation—a universally strong signal of ill health associated with all nine hallmarks of aging and diseases that collectively represent the leading causes of disability and mortality worldwide—can now be measured by an inflammatory clock of aging (iAge) developed by investigators at the Stanford University School of Medicine and the Buck Institute for Research on Aging. It is the first “actionable clock” that predicts multimorbidity, frailty, immunological health, and chronic diseases of aging.
    Full story
  • Rho to Coordinate Study Sponsored by NIAID to Assess Systemic Allergic Reactions to Pfizer and Moderna COVID-19 Vaccines

    Jul 14, 2021, 12:21 PM by
    Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced it is coordinating a study called Systemic Allergic Reactions to SARS-CoV-2 Vaccination to assess the proportion of participants with a systemic allergic reaction to the Pfizer-BioNTech and Moderna COVID-19 vaccines in populations at high risk for allergic reaction compared to a general population. This research will be important for further understanding potential risk factors for an allergic reaction to these particular vaccines, as well as to future vaccines that similarly use an mRNA nanoparticle platform. The study is sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
    Full story